(-0.01%) 5 307.50 points
(0.00%) 40 144 points
(-0.01%) 18 502 points
(1.32%) $82.42
(-1.51%) $1.692
(1.82%) $2 230.40
(0.02%) $24.76
(0.31%) $912.50
(0.35%) $0.927
(0.56%) $10.83
(0.12%) $0.792
(-0.26%) $92.20
Live Chart Being Loaded With Signals
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia...
Stats | |
---|---|
Today's Volume | 292 755 |
Average Volume | 700 252 |
Market Cap | 106.93M |
EPS | $0 ( 2024-02-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.500 |
ATR14 | $0.00200 (0.57%) |
Volume Correlation
Paradigm Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Paradigm Correlation - Currency/Commodity
Paradigm Financials
Annual | 2023 |
Revenue: | $46 760.00 |
Gross Profit: | $-125 723 (-268.87 %) |
EPS: | $-0.180 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-73 397.00 (0.00 %) |
EPS: | $-0.160 |
Q4 | 2023 |
Revenue: | $42 050.00 |
Gross Profit: | $-46 172.00 (-109.80 %) |
EPS: | $-0.0692 |
Q2 | 2023 |
Revenue: | $4 710.00 |
Gross Profit: | $-79 551.00 (-1 688.98 %) |
EPS: | $-0.120 |
Financial Reports:
No articles found.
Paradigm
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators